300529 健帆生物
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额411,211721,2161,050,988916,744883,800
投资活动产生之现金流量净额(1,853,841)643,153(1,127,472)(249,649)(305,901)
筹资活动产生之现金流量净额(540,044)(563,332)(989,821)(451,911)(365,934)
汇率变动对现金及现金等价物的影响(3,894)(1,723)42811(36)
现金及现金等价物净增加/(减少)(1,986,567)799,315(1,065,877)215,195211,929
期初现金及现金等价物余额2,474,9821,675,6662,741,5432,526,3492,314,420
期末现金及现金等价物余额488,4142,474,9821,675,6662,741,5432,526,349